Carboxyhemoglobin formed following exposure to carbon monoxide decreases at a rate affected by oxygen exposure. Hyperbaric oxygen therapy can reduce the half life of carboxyhemoglobin by over 90% as compared to breathing room air. Increasing oxygen exposure can significantly reduce the time to elimination with reduced morbidity and mortality.